Latest Management of cancer Stories
Alexander Chi, MD, a thoracic radiation oncologist at West Virginia University, is the principal investigator in the study of novel treatment approaches for non-small cell lung cancer.
MARLBOROUGH, Mass., March 27, 2015 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII) and privately-held MirImmune LLC, today announced that they have entered into an exclusive license
According to the new report from BCC Research, the global market for biologic cancer treatment totaled about $51.2 billion in 2014 and is expected to reach $66.4 billion in 2019, registering a
11 Presentations at St.
More than one third of all breast cancer survivors experience post-treatment cognitive issues, but researchers from UCLA are working on a new rehab program designed to help those women deal with and eventually overcome the condition known as “chemo brain".
LONDON, March 17, 2015 /PRNewswire/ -- Executive Summary--The global breast cancer therapeutics market is divided into x segments: hormonal therapy, targeted therapy, chemotherapy,
MELBOURNE, Australia, March 17, 2015 /PRNewswire/ -- Propanc Health Group Corporation (OTCPK: PPCH) ("Propanc" or "the Company"), an emerging healthcare company focusing on the development of
Company CEO to Showcase the Potential of Its Science SAN ANTONIO, March 17, 2015 /PRNewswire/ -- GenSpera Inc.
The use of combination targeted therapies will improve progression-free disease as well as survival rates, finds Frost & Sullivan LONDON, March 17, 2015 /PRNewswire/ -- Despite the availability
The Stamford, CT-based nonprofit continues its mission to treat and defeat cancer by funding two new oncologists at top research facilities Stamford, CT (PRWEB)